Skip to main content

Table 3 Gene-smoking and gene-diabetes interaction in patients with CAD cases and controls

From: Association in a Chinese population of a genetic variation in the early B-cell factor 1 gene with coronary artery disease

Variables

 

CAD cases

Controls

OR (95% CI)

P

adjusted OR a (95% CI)

P

rs36071027

Smoking

      

CC

No

132 (45.1)

160 (61.1)

1

 

1

 

CC

Yes

79 (27.0)

51 (19.5)

1.88 (1.23–2.86)

0.003

1.89 (1.15–3.12)

0.012

CT + TT

No

54 (18.4)

38 (14.5)

1.72 (1.07–2.77)

0.025

1.80 (1.11–2.93)

0.017

CT + TT

Yes

28 (9.6)

13 (5.0)

2.61 (1.30–5.24)

0.007

2.55 (1.22–5.30)

0.013

P interation

    

0.882

 

0.747

rs36071027

Diabetes

      

CC

No

147 (50.2)

165 (63.0)

1

 

1

 

CC

Yes

64 (21.8)

46 (17.6)

1.56 (1.01–2.42)

0.047

1.58 (1.00–2.49)

0.050

CT + TT

No

54 (18.4)

43 (16.4)

1.41 (0.89–2.23)

0.142

1.40 (0.88–2.23)

0.160

CT + TT

Yes

28 (9.6)

8 (3.1)

3.93 (1.74–8.89)

0.001

3.84 (1.68–8.78)

0.001

P interation

    

0.249

 

0.280

  1. Abbreviations: OR, odds ratio; CI, confidence interval
  2. aLogistic regression model, adjusted by age, sex, hypertension, diabetes, smoking, body mass index and hyperlipidemia